ReviewOncology reviews2026

A new paradigm for retroperitoneal leiomyosarcoma: integrating transcriptomic subtyping and surgical risk stratification for AI-guided drug repurposing.

Nan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.